Skip to content
healthcare.dev

Sucralfate oral suspension

NDC 68462-827, sucralfate, suspension, from Glenmark Pharmaceuticals Inc., USA.

Product NDC
68462-827
Status
Listed
Labeler
Glenmark Pharmaceuticals Inc., USA
Dosage form
SUSPENSION
Route
ORAL
Product type
HUMAN PRESCRIPTION DRUG
Marketing category
ANDA
Application
ANDA212141
DEA schedule
None
Request
curl https://api.healthcare.dev/v1/drugs/ndc/68462-827 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • SUCRALFATE1 g/10mL

Pharmacologic classes

Aluminum Complex [EPC]; Organometallic Compounds [CS]

Package NDCNDC-11Package
68462-827-6168462082761420 mL in 1 BOTTLE (68462-827-61)

Linked data

RxNorm, label and prices

RxNorm concepts

Related lookups

  • FDA label sections

    GET /v1/drugs/labels/1e595c2a-edd0-43f7-a2db-69553b9557d9

Use it

Look up 68462-827 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/68462-827 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 68462-827. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.